Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The market for vaccine in the United States is being aided by the increasing research activities in genetic engineering and biotechnology to determine the genotype of antigens. This is also expected to increase the development of critical vaccines like parasitic and bacterial to prevent the risk of infection of chronic diseases, such as cancer, pulmonary obstructive chronic disease (PCOS), and acquired immunodeficiency syndrome (AIDS), among others. Moreover, the increasing clinical trials to determine the efficacy of vaccines and prevent the risk of side effects are expected to fuel the growth of the market. The surging use of the latest technologies, such as machine learning and artificial intelligence (AI), to automate various research activities while providing meaningful insights to accelerate vaccine development is projected to further propel the growth of the vaccine industry in the forecast period.
Pfizer Inc. (NYSE: PFE), one of the leading companies in the market, along with BioNTech, announced in September 2021 that the booster dose of the Pfizer-BioNTech COVID-19 vaccine is authorised by the Food and Drug Administration (FDA) of the United States for emergency use. The shot is authorised for individuals above or 65 years of age and at high risk of COVID-19 infection in individuals of 18-64 years with comorbidities or frequent exposure to the novel virus. The authorisation is based on the clinical data that support the clinical understanding that a booster shot provides enhanced protection against variants of SARS-CoV-2 to prevent fatality and complications in the case of COVID-19 infection. The companies are expected to supply boosters to the United States government through April 2022 under their supply agreement. Such developments are expected to aid the market growth.
Market Analysis by Technology, Indication, End Use, and Region:
Key Findings of the Report:
Key Offerings of the Report:
The major players in the United States vaccine market are GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, AstraZeneca plc, and Johnson & Johnson Services, Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.